Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TYMS | P04818 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL36120 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL5807840 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL3516998 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL2033777 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL1859411 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL14119636 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL25166911 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL234306 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL21293873 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL3946 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611098-A1 | SOLID ELECTROLYTE AND ELECTRODE FOR A SOLID-STATE BATTERY COMPRISING FUNCTIONAL FILLERS AND DISPERSING AGENTS, AND METHODS FOR PRODUCING THE SAME | SOLiTHOR (BE) | 2025-09-03 | — | — | EP | claimed |
| CN-117446951-A | Aeration combined Fe 2+ /O 2 Method for treating groundwater with ligand system | 吉林大学 | 2024-01-26 | — | — | CN | claimed |
| CN-116789504-A | Method for improving freezing resistance of liquid macroelement water-soluble fertilizer | 广西东林食品化工有限公司 | 2023-09-22 | — | — | CN | claimed |
| EP-0105063-B1 | LIQUID HARD-SURFACE CLEANER | THE PROCTER & GAMBLE COMPANY (US) | 1986-12-30 | — | — | EP | claimed |
| EP-0105063-A1 | Liquid hard-surface cleaner | THE PROCTER & GAMBLE COMPANY (US) | 1984-04-11 | — | — | EP | claimed |
| US-12582585-B2 | Peroxymonosulfate oral whitening compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12551429-B2 | Oral care complexes and compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-02-17 | — | — | US | disclosed |
| EP-4642421-A1 | PEROXYMONOSULFATE ORAL WHITENING COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4637688-A1 | ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4626388-A1 | PEROXYMONOSULFATE ORAL WHITENING COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-4622620-A1 | PEROXYMONOSULFATE ORAL WHITENING COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4611098-A1 | SOLID ELECTROLYTE AND ELECTRODE FOR A SOLID-STATE BATTERY COMPRISING FUNCTIONAL FILLERS AND DISPERSING AGENTS, AND METHODS FOR PRODUCING THE SAME | SOLiTHOR (BE) | 2025-09-03 | — | — | EP | disclosed |
| US-20100248151-A1 | METHOD OF MAKING A PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| WO-2008156330-A1 | USE OF XANTHORRHIZOL FOR ANTI-WRINKLE TREATMENT | BIOCARE CO., LTD. (KR) | 2008-12-24 | — | — | WO | disclosed |
| CN-1443236-A | Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme | HENKEL KGAA (DE) | 2003-09-17 | — | — | CN | disclosed |
| WO-1994009253-A1 | COMPOSITION FOR USE IN WELL DRILLING AND MAINTENANCE | GAIT PRODUCTS LIMITED (GB) | 1994-04-28 | — | — | WO | disclosed |
| EP-0029497-B1 | ASPOROGENOUS MUTANT OF BACILLUS SUBTILIS AND PROCESS FOR THE USE THEREOF AS HOST COMPONENT OF A HV1 SYSTEM | THE UNIVERSITY OF ROCHESTER (US) | 1985-01-23 | — | — | EP | disclosed |
| US-4395364-A | LAUNDERING; RINSING; FOAMING | KAO SOAP CO., LTD. (JP) | 1983-07-26 | — | — | US | disclosed |
| US-4302544-A | Asporogenous mutant of B. subtilis for use as host component of HV1 system | UNIVERSITY OF ROCHESTER (US) | 1981-11-24 | — | — | US | disclosed |
| US-4148938-A | Protecting pavement materials against the effects of freezing and thawing of water or brine solutions | HANSEN CHARLES N | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582585-B2 | Peroxymonosulfate oral whitening compositions | KCNN3, KCNN1, POLR1C | CA2 297/4885SLC34A1 262/4885FDPS 3579/4885 |
| US-12551429-B2 | Oral care complexes and compositions | ARGLU1, ARG1, PELP1 | CA2 289/4885SLC34A1 1691/4885FDPS 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.